Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1726 to 1740 of 7682 results

  1. Emtricitabine/tenofovir alafenamide for human immunodeficiency virus type-1 infection [TS ID 10723]

      Status ...

    Technology appraisal guidance
    Topic selection

  2. Dupilumab for maintenance treatment of uncontrolled moderate to severe asthma in children 6 to 11 years [TS ID 10085]

      Status ...

    Technology appraisal guidance
    Topic selection

  3. Dupilumab for children with severe atopic dermatitis [TS ID 10434]

      Status ...

    Technology appraisal guidance
    Topic selection

  4. Zamtocabtagene autoleucel for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more therapies TS ID 10765

    Awaiting development [GID-TA11050] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  5. REGN5458 for treating relapsed or refractory multiple myeloma TS ID 10443

    Awaiting development [GID-TA11052] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  6. Dulaglutide for treating type 2 diabetes in children and young people TS ID 10660

      Status ...

    Technology appraisal guidance
    Topic selection

  7. Estetrol for treating vasomotor symptoms associated with the menopause in people aged 40 to 65 ID4037

    Awaiting development [GID-TA11059] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  8. Lumella Pre-Eclampsia Test (MT687)

      Status ...

    Diagnostics guidance
    Topic selection

  9. TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MT512)

      Status ...

    Medical technologies guidance
    Topic selection

  10. Bladder EpiCheck for the detection of bladder cancer recurrence (MT706)

      Status ...

    Diagnostics guidance
    Topic selection

  11. Cenobamate for adjunctive treatment of primary generalised tonic-clonic seizures in epilepsy TS ID 10214

    Awaiting development [GID-TA11069] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  12. Mavorixafor for treating WHIM syndrome ID3946

    Awaiting development [GID-TA10833] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  13. Safe prescribing and withdrawal management of prescribed drugs associated with dependence and withdrawal

    Awaiting development [GID-QS10106] Expected publication date: TBC

    Quality standard
    Awaiting development

  14. Ixazomib citrate for maintenance treatment of untreated multiple myeloma after autologous stem cell transplant [ID1517]

    Awaiting development [GID-TA10843] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  15. Safeguarding adults in care homes

    Awaiting development [GID-QS10147] Expected publication date: TBC

    Quality standard
    Awaiting development